Buffer
|
Mouse 1 |
Councilman bodies. 15 infiltrate foci (16–52 µm). Marked steatosis |
Mouse 2 |
Councilman bodies. 29 infiltrate foci (10–114 µm). Mild steatosis |
Mouse 3 |
Councilman bodies. 22 infiltrate foci (20–52 µm). Mild steatosis |
Mouse 4 |
3 infiltrate foci (15–34 µm) |
Mouse 5 |
Necrotic lesion (325 µm). Councilman bodies. 17 infiltrate foci (17–104 µm). Mild steatosis |
Mouse 6 |
Necrotic lesions (212 and 43 µm). Councilman bodies. 18 infiltrate foci (15–52 µm). Mild steatosis |
Buffer + adjuvant
|
Mouse 1 |
Councilman bodies. 6 infiltrate foci (18–27 µm). Small patches of steatosis. |
Mouse 2 |
Necrotic lesion (105 µm). Councilman bodies. 16 infiltrate foci (22–54 µm) |
Mouse 3 |
Councilman bodies. 16 infiltrate foci (21–63 µm) |
Mouse 4 |
Necrotic lesions (342 and 197 µm). Councilman bodies. 14 infiltrate foci (16–108 µm). Areas of marked steatosis |
Mouse 5 |
Councilman bodies. 22 infiltrate foci (17–109 µm). Small patches of steatosis |
Mouse 6 |
Necrotic lesions (357 and 123 µm). Councilman bodies. 30 infiltrate foci (21–79 µm) |
5 µg
BinJ/YFV-prME + adjuvant
|
Mouse 1 |
7 infiltrate foci (29–53 µm) |
Mouse 2 |
6 infiltrate foci (15–38 µm) |
Mouse 3 |
11 infiltrate foci (12–42 µm) |
Mouse 4 |
11 infiltrate foci (13–77 µm) |
Mouse 5 |
6 infiltrate foci (18–82 µm) |
Mouse 6 |
7 infiltrate foci (18–34 µm) |
20 µg
BinJ/YFV-prME + adjuvant
|
Mouse 1 |
5 infiltrate foci (14–28 µm) |
Mouse 2 |
5 infiltrate foci (21–50 µm) |
Mouse 3 |
5 infiltrate foci (24–44 µm) |
Mouse 4 |
5 infiltrate foci (19–35 µm) |
Mouse 5 |
6 infiltrate foci (19–139 µm) |
Mouse 6 |
3 infiltrate foci (26–43 µm) |
Naïve mice (no vaccine, no challenge)
|
Mouse 1 |
2 infiltrate foci (24–31 µm) |
Mouse 2 |
3 infiltrate foci (31–69 µm) |
Mouse 3 |
2 infiltrate foci (26–69 µm) |
Mouse 4 |
1 infiltrate foci (32 µm) |
Mouse 5 |
3 infiltrate foci (11–22 µm) |
Mouse 6 |
0 infiltrate foci |